|
3- [3-(9H-咔唑-9-基)苯基]呋喃[2,3-b:5,4-b']二吡啶
|
H290084-1g
|
升华级, ≥99%(HPLC) |
1443793-91-6 |
1g
|
¥ 15205.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3'-(9H-咔唑-9-基)联苯-3,5-二甲腈
|
H290077-1g
|
升华级, ≥99%(HPLC) |
1646323-60-5 |
1g
|
¥ 8725.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4,4'-(9H,9'H-3,3'-联咔唑-9,9'-二基)双(N,N-二苯基苯胺)
|
H290076-1g
|
升华级, ≥99%(HPLC) |
1032174-52-9 |
1g
|
¥ 18196.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
9-(5-(3-(9H-咔唑-9-基)苯基)吡啶-3-基)-9H-咔唑
|
H290071-1g
|
≥99%(HPLC) |
1583238-16-7 |
1g
|
¥ 10923.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4,6-双(3-(9H-咔唑-9-基)苯基)嘧啶
|
H290065-1g
|
升华级, ≥99% |
1262678-77-2 |
1g
|
¥ 5149.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(4-(9H-咔唑-9-基)苯基)-9-(4,6-二苯基-1,3,5-三嗪-2-基)-9H-咔唑
|
H290064-1g
|
升华级, ≥99%(HPLC) |
1407183-68-9 |
1g
|
¥ 13846.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
9-(4-(9H-吡啶基[2,3-b]吲哚-9-基)苯基)-9H -3,9'-联咔唑
|
H290063-1g
|
升华级, ≥99%(HPLC) |
1446517-60-7 |
1g
|
¥ 10787.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(3-(9H-咔唑-9-基)苯基)苯并[4,5]噻吩并[2,3-b]吡啶
|
H290061-1g
|
升华级, ≥99%(HPLC) |
1421599-23-6 |
1g
|
¥ 9359.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(3-(9H-咔唑-9-基)苯基)苯并呋喃[2,3-b]吡啶56/50003-(3-(9H-咔唑-9-基)苯基)苯并呋喃[2,3-b]吡啶
|
H290060-1g
|
升华级, ≥99%(HPLC) |
1424369-36-7 |
1g
|
¥ 10311.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
[9-[3-(9H-咔唑-9-基)苯基]-9H-咔唑-3-基]二苯基氧膦
|
H290054-1g
|
升华级, ≥99%(HPLC) |
1296229-26-9 |
1g
|
¥ 12486.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
9,9'-[1,4-亚苯基二(亚甲基)]二-9H-咔唑
|
H290041-1g
|
≥99%(HPLC) |
166256-60-6 |
1g
|
¥ 3966.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,3,8,9,14,15-六氟二喹啉并[2,3-a:2',3'-c]吩嗪
|
H290027-1g
|
升华级, ≥99% |
872140-95-9 |
1g
|
¥ 20259.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,3,8,9,14,15-六氯二喹啉并[2,3-a:2',3'-c]吩嗪
|
H290026-1g
|
升华级, ≥99% |
389121-44-2 |
1g
|
¥ 12373.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4,4'-(9H-芴-9-亚烷基)双[N,N-双(4-甲基苯基)-苯甲胺
|
H290014-1g
|
升华级, ≥99%(HPLC) |
159526-57-5 |
1g
|
¥ 7546.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,1',3,3,3',3'-六甲基吲哚三羰花青高氯酸盐
|
H289967-1g
|
≥97%(HPLC) |
16595-48-5 |
1g
|
¥ 9200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
碘化-1,1ˊ,3,3,3ˊ,3ˊ-六甲基吲哚三羰花青
|
H289966-1g
|
≥97%(HPLC) |
19764-96-6 |
1g
|
¥ 6663.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,1',3,3,3',3'-六甲基吲哚双碳菁碘
|
H289964-1g
|
≥98%(HPLC) |
36536-22-8 |
1g
|
¥ 4283.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
溴氯哌喹酮 氢溴酸盐
|
H288889-50mg
|
≥98%(HPLC) |
64924-67-0 |
50mg
|
¥ 396.9
|
现货 |
|
0 |
阿拉丁 |
|
8-羟基-PIPAT草酸酯
|
H288851-50mg
|
≥98%(HPLC) |
1451210-48-2 |
50mg
|
¥ 6510.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
8-羟基-PIPAT草酸酯
|
H288851-10mg
|
≥98%(HPLC) |
1451210-48-2 |
10mg
|
¥ 1721.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
HLM 006474,E2F转录因子抑制剂
|
H288701-50mg
|
≥98%(HPLC) |
353519-63-8 |
50mg
|
¥ 930.9
|
现货 |
|
0 |
阿拉丁 |
|
HLM 006474,E2F转录因子抑制剂
|
H288701-10mg
|
≥98%(HPLC) |
353519-63-8 |
10mg
|
¥ 621.9
|
现货 |
|
0 |
阿拉丁 |
|
HJC 0350,Epac2抑制剂
|
H288693-50mg
|
Moligand™, ≥98%(HPLC) |
885434-70-8 |
50mg
|
¥ 2265.9
|
现货 |
|
0 |
阿拉丁 |
|
HJC 0350,Epac2抑制剂
|
H288693-10mg
|
Moligand™, ≥98%(HPLC) |
885434-70-8 |
10mg
|
¥ 546.9
|
现货 |
|
0 |
阿拉丁 |